You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

orteronel

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in United States (Orteronel)

Completed
Has Results
  • Metastatic Breast Cancer
  • Orteronel
  • New Haven, Connecticut
  • +9 more
Jun 8, 2022

Post Menopausal, Hormone Receptor Positive Breast Cancer Trial in Madison (TAK700)

Completed
  • Post Menopausal, Hormone Receptor Positive Breast Cancer
  • Madison, Wisconsin
    University of Wisconsin
Nov 14, 2019

Prostate Cancer Trial in Switzerland (Orteronel, Placebo)

Completed
  • Prostate Cancer
  • Orteronel
  • Placebo
  • Aarau, Switzerland
  • +14 more
May 13, 2019

Prostatic Tumors, Prostate Cancer Trial in Madison (drug, radiation, procedure)

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 19, 2019

Prostate Cancer Trial in Worldwide (Orteronel, Prednisone, Orteronel Placebo)

Completed
Has Results
  • Prostate Cancer
  • Orteronel
  • +2 more
  • Anchorage, Alaska
  • +78 more
Nov 28, 2018

Prostate Cancer Trial in Switzerland (Orteronel, Placebo)

Withdrawn
  • Prostate Cancer
  • Orteronel
  • Placebo
  • Baden, Switzerland
  • +6 more
Jul 26, 2018

Prostate Cancer Trial in Omaha (Orteronel, Orteronel Placebo, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Orteronel
  • +2 more
  • Omaha, Nebraska
    Urology Cancer Center, PC
Feb 19, 2018

Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors Trial in Spain (Orteronel 300mg BID)

Terminated
  • Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors
  • Orteronel 300mg BID
  • Palma de Mallorca, Islas Baleares, Spain
  • +8 more
Mar 2, 2018

Prostate Cancer Trial in Anchorage (TAK-700, Docetaxel, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Anchorage, Alaska
    Alaska Clinical Research Center, LLC
Jul 9, 2019

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (orteronel,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • orteronel
  • laboratory biomarker analysis
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 31, 2017

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in London (TAK-700 and LHRH agonist, prostatectomy)

Terminated
  • Prostate Cancer
  • TAK-700 and LHRH agonist
  • prostatectomy
  • London, United Kingdom
    St Bartholomew's Hospital
Jul 6, 2017

Prostate Cancer Trial in Worldwide (Orteronel, Placebo, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Orteronel
  • +2 more
  • Anchorage, Alaska
  • +244 more
Apr 7, 2017

Prostate Cancer Trial in Scottsdale (Orteronel+Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Scottsdale, Arizona
    Pinnacle Oncology
Apr 24, 2016

Prostate Cancer Trial in Belgium (Orteronel, Bicalutamide)

Withdrawn
  • Prostate Cancer
  • Aals, Belgium
  • +3 more
Jun 9, 2016

Prostate Cancer, Castration-resistant Prostate Cancer Trial in Washington, Baltimore, Detroit (Itraconazole, Orteronel)

Withdrawn
  • Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Washington, District of Columbia
  • +2 more
Jul 22, 2014

Breast Tumors Trial (Bicalutamide, Physician's Choice)

Unknown status
  • Breast Neoplasms
  • (no location specified)
Feb 2, 2015